These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26280165)

  • 21. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
    Shahid HS; Kurdi MI; Zohair AA
    Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-sensitivity C-reactive protein is associated with the risk of coronary heart disease as estimated by the Framingham Risk Score in middle-aged Japanese men.
    Otsuka T; Kawada T; Katsumata M; Ibuki C; Kusama Y
    Int J Cardiol; 2008 Sep; 129(2):245-50. PubMed ID: 17997174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity".
    Coutinho T; Goel K; Corrêa de Sá D; Carter RE; Hodge DO; Kragelund C; Kanaya AM; Zeller M; Park JS; Kober L; Torp-Pedersen C; Cottin Y; Lorgis L; Lee SH; Kim YJ; Thomas R; Roger VL; Somers VK; Lopez-Jimenez F
    J Am Coll Cardiol; 2013 Feb; 61(5):553-60. PubMed ID: 23369419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
    Morrow DA; de Lemos JA; Sabatine MS; Wiviott SD; Blazing MA; Shui A; Rifai N; Califf RM; Braunwald E
    Circulation; 2006 Jul; 114(4):281-8. PubMed ID: 16847150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
    Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
    Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.
    Dieset I; Hope S; Ueland T; Bjella T; Agartz I; Melle I; Aukrust P; Røssberg JI; Andreassen OA
    Schizophr Res; 2012 Sep; 140(1-3):169-74. PubMed ID: 22817875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentation.
    Hudzik B; Danikiewicz A; Szkodzinski J; Polonski L; Zubelewicz-Szkodzinska B
    Eur Cytokine Netw; 2014; 25(3):41-5. PubMed ID: 25373851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body mass index and mortality from ischaemic heart disease in a lean population: 10 year prospective study of 220,000 adult men.
    Chen Z; Yang G; Zhou M; Smith M; Offer A; Ma J; Wang L; Pan H; Whitlock G; Collins R; Niu S; Peto R
    Int J Epidemiol; 2006 Feb; 35(1):141-50. PubMed ID: 16258057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increases in body mass index over a 7-year period and risk of cause-specific mortality in Korean men.
    Yun KE; Park HS; Song YM; Cho SI
    Int J Epidemiol; 2010 Apr; 39(2):520-8. PubMed ID: 19762478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of very high high-sensitivity C-reactive protein levels on mortality after stroke.
    Itrat A; Griffith SD; Alam S; Thompson N; Katzan IL
    J Neurol Sci; 2017 Jan; 372():1-5. PubMed ID: 28017191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relation of body mass index to outcome in patients with known or suspected coronary artery disease.
    Galal W; van Domburg RT; Feringa HH; Schouten O; Elhendy A; Bax JJ; Awara AM; Klein J; Poldermans D
    Am J Cardiol; 2007 Jun; 99(11):1485-90. PubMed ID: 17531566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
    Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
    Rasouli M; Kiasari AM
    Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease.
    Taniguchi H; Momiyama Y; Ohmori R; Yonemura A; Yamashita T; Tamai S; Nakamura H; Ohsuzu F
    Atherosclerosis; 2005 Jan; 178(1):173-7. PubMed ID: 15585215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis.
    Sharma A; Vallakati A; Einstein AJ; Lavie CJ; Arbab-Zadeh A; Lopez-Jimenez F; Mukherjee D; Lichstein E
    Mayo Clin Proc; 2014 Aug; 89(8):1080-100. PubMed ID: 25039038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can C-reactive protein predict cardiovascular events in asymptomatic patients? Analysis based on plaque characterization.
    Park HE; Cho GY; Chun EJ; Choi SI; Lee SP; Kim HK; Youn TJ; Kim YJ; Choi DJ; Sohn DW; Oh BH; Park YB
    Atherosclerosis; 2012 Sep; 224(1):201-7. PubMed ID: 22840693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.
    Pfützner A; Standl E; Strotmann HJ; Schulze J; Hohberg C; Lübben G; Pahler S; Schöndorf T; Forst T
    Clin Chem Lab Med; 2006; 44(5):556-60. PubMed ID: 16681424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The obesity paradox, weight loss, and coronary disease.
    Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
    Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East Asians.
    Sung KC; Ryu S; Chang Y; Byrne CD; Kim SH
    Eur Heart J; 2014 Jul; 35(27):1809-16. PubMed ID: 24569028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.